纳指生物科技ETF(513290)
动态评分: 5.70分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2024-12-31 | PTCT | PTC Therapeutics Inc | 530.63 | 0.35% |
2024-12-31 | ALVO | Alvotech | 538.05 | 0.35% |
2024-12-31 | VRNA | 维罗纳制药 | 523.68 | 0.34% |
2024-12-31 | RYTM | Rhythm Pharmaceuticals Inc | 524.38 | 0.34% |
2024-12-31 | CRSP | CRISPR Therapeutics AG | 512.06 | 0.34% |
2024-12-31 | NVCR | NovoCure Ltd | 491.47 | 0.32% |
2024-12-31 | VCYT | Veracyte Inc | 467.78 | 0.31% |
2024-12-31 | ACAD | 阿卡迪亚 | 465.38 | 0.3% |
2024-12-31 | XENE | Xenon制药 | 455.53 | 0.3% |
2024-12-31 | MRUS | Merus NV | 438.81 | 0.29% |
2024-12-31 | DNLI | Denali Therapeutics Inc | 447.07 | 0.29% |
2024-12-31 | JANX | Janux Therapeutics Inc | 428.28 | 0.28% |
2024-12-31 | FOLD | 爱美医疗 | 429.03 | 0.28% |
2024-12-31 | TWST | Twist Bioscience Corp | 420.43 | 0.28% |
2024-12-31 | VCEL | Vericel Corp | 413.11 | 0.27% |
2024-12-31 | VERA | Vera Therapeutics Inc-A | 408.18 | 0.27% |
2024-12-31 | LEGN | Legend Biotech Corp ADR | 405.13 | 0.27% |
2024-12-31 | SWTX | SpringWorks Therapeutics Inc | 409.65 | 0.27% |
2024-12-31 | RXRX | Recursion Pharmaceuticals Inc-A | 393.33 | 0.26% |
2024-12-31 | KYMR | Kymera Therapeutics Inc | 397.14 | 0.26% |
公告&资料
